Thirumalai Chemicals.is currently trading at Rs. 236.55, up by 4.50 points or 1.94% from its previous closing of Rs. 232.05 on the BSE.
The scrip opened at Rs. 236.15 and has touched a high and low of Rs. 237.65 and Rs. 234.35 respectively. So far 14232 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 244.20 on 05-Sep-2023 and a 52 week low of Rs. 168.35 on 28-Mar-2023.
Last one week high and low of the scrip stood at Rs. 237.65 and Rs. 227.30 respectively. The current market cap of the company is Rs. 2412.26 crore.
The promoters holding in the company stood at 41.98%, while Institutions and Non-Institutions held 2.05% and 55.97% respectively.
Thirumalai Chemicals’ wholly owned subsidiary -- TCL Intermediates has commenced commercial production on January 10, 2024, from its Greenfield plant at Dahej. The product manufactured is Fumaric Acid. This is expected to augment a revenue by about Rs 4 crore from its operations for the quarter ending March 2024.
Thirumalai Chemicals (TCL) is a publicly listed company in India. TCL ranks among the largest producers in the world of Phthalic Anhydride, Malic Acid, Maleic Anhydride and Fumaric Acid. As a Responsible Care Company, safety, integrity and people are their main pillars.
| Company Name | CMP |
|---|---|
| BASF India | 4035.90 |
| Tata Chemicals | 782.10 |
| SRF | 2780.75 |
| Pidilite Inds. | 1476.15 |
| Deepak Nitrite | 1875.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: